Oral Effects and Early Implant Survival Results After Imatinib Discontinuation Therapy for Chronic Myelogenous Leukemia: A Case Report

Clinical advances in periodontics - United States
doi 10.1902/cap.2016.160050
Full Text
Abstract

Available in full text

Categories
Periodontics
Date
Authors
Publisher

Wiley

Related search

Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia

Clinical Journal of Oncology Nursing
Oncology
2009English

Characteristics of Dasatinib- And Imatinib-Resistant Chronic Myelogenous Leukemia Cells

Clinical Cancer Research
Cancer ResearchOncology
2008English

Successful Delivery After Planned Discontinuation of Imatinib in a Patient With Chronic Myeloid Leukemia

Internal Medicine
Internal MedicineMedicine
2009English

Pharmacotherapy for Chronic Myelogenous Leukemia: A Case-Based Approach

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Higher Dose Imatinib for Children With De Novo Chronic Phase Chronic Myelogenous Leukemia: A Report From the Children's Oncology Group

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2011English

Sweet's Syndrome After Splenic Irradiation for Chronic Myelogenous Leukemia

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1996English

Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia

Cancer Research
Cancer ResearchOncology
2004English

Complex Chromosomal Rearrangements Involving Five Chromosomes in Chronic Myelogenous Leukemia: A Case Report

Oncology Letters
Cancer ResearchOncology
2016English

Increased Cortical Bone Mineralization in Imatinib Treated Patients With Chronic Myelogenous Leukemia

Haematologica
Hematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy